GENB
Generate Biomedicines, Inc.
NASDAQ · Financial Services · Asset Management · US
$16.39
+0.31%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 104.30x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 4.61x
- Price / sales
- 65.96x
- Price / cash flow
- -10.49x
Enterprise value
- Enterprise value
- $1.7B
- EV / sales
- 53.58x
- EV / EBITDA
- -8.20x
- EV / EBIT
- -7.27x
- Market cap
- $2.1B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026